VICTORY CAPITAL MANAGEMENT INC
Position in BMY — Bristol Myers Squibb Co
CIK 1040188
San Antonio, TX
Position in BMY
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$555,020,947
+$112,474,748 QoQ
Shares Held
9,151,211
+11.5% QoQ
Ownership
0.448%
of shares outstanding
% of Portfolio
0.38%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 66.38044953831793.ToString("F0")%
Shared 0.ToString("F0")%
None 33.61955046168207.ToString("F0")%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026VICTORY CAPITAL MANAGEMENT INC holds $5,020,049,253 across 14 Drug Manufacturers - General names. BMY ranks #3 (11.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,866,854 | $1,717,076,303 | |
| 2 | JNJ |
Johnson & Johnson
|
3,429,005 | $838,185,982 | |
| 3 | BMY |
Bristol Myers Squibb Co
This page
|
9,151,211 | $555,020,947 | |
| 4 | MRK |
Merck & Co., Inc.
|
3,789,757 | $455,869,869 | |
| 5 | PFE |
Pfizer Inc
|
15,508,999 | $435,492,691 | |
| 6 | ABBV |
AbbVie Inc.
|
1,523,989 | $331,452,367 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
2,161,094 | $301,191,670 | |
| 8 | AMGN |
Amgen Inc
|
642,962 | $226,226,179 |
All Filings in BMY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $555,020,947 | 9,151,211 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $442,546,199 | 8,204,416 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $183,090,260 | 4,059,651 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $151,603,684 | 3,275,085 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $296,595,589 | 4,863,020 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $162,549,933 | 2,873,938 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $153,425,760 | 2,965,322 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $157,041,375 | 3,781,396 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $195,027,132 | 3,596,296 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $137,514,237 | 2,680,067 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $120,437,411 | 2,075,076 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $103,503,138 | 1,618,501 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $136,210,021 | 1,965,229 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $160,958,697 | 2,237,091 | Shares | Sole | 2023-04-25 | |
| 2022-09-30 | $161,760,603 | 2,275,434 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $154,975,821 | 2,012,673 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $142,183,786 | 1,946,923 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $82,446,215 | 1,322,313 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $76,907,390 | 1,299,770 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $96,153,712 | 1,438,996 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $92,587,720 | 1,466,620 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $110,019,943 | 1,773,657 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $179,109,351 | 2,970,797 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $180,037,956 | 3,061,870 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $177,984,508 | 3,193,120 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||